Lantheus Holdings Share | Buy US Stock from India on Kuvera

Q: Can I buy Lantheus Holdings shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Lantheus Holdings stocks after a simple registration process. </div>

Q: How to buy Lantheus Holdings shares in India?

<div> To buy Lantheus Holdings shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Lantheus Holdings and you are done!</div> </div>

Q: What is the share price of Lantheus Holdings?

<div>The share price of Lantheus Holdings is USD 91.43 as on 17 Jan.</div>

Q: What is the Market Capitalization of Lantheus Holdings?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Lantheus Holdings is USD 6.36B as on 17 Jan.</div>

Q: What is the PE ratio of Lantheus Holdings?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Lantheus Holdings is 15.21 as on 17 Jan. </div>

Q: Is Lantheus Holdings a good stock to buy?

<div>Kuvera provides relevant fundamental details of Lantheus Holdings to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Lantheus Holdings operate?

<div> Lantheus Holdings operates in Healthcare / Drug manufacturers - specialty & generic

Healthcare Drug manufacturers - specialty & generic

$91.43

-0.12

(17 Jan)

Loading Chart

Previous close

$91.43

Open

$91.43

Today’s high

$92.80

Today’s low

$90.50

52W low

$50.20

52W high

$126.89

66.15%

37.00%

15.21

EPS (TTM)

6.02

Shares O/S

69.53M

Market cap

6.36B

Insights

LNTH is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Lantheus Holdings

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer.

Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol. .

FAQs

Can I buy Lantheus Holdings shares in India?

How to buy Lantheus Holdings shares in India?

What is the share price of Lantheus Holdings?

What is the Market Capitalization of Lantheus Holdings?

What is the PE ratio of Lantheus Holdings?

Is Lantheus Holdings a good stock to buy?

In which sector / industry does Lantheus Holdings operate?